Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

NCT05184491 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori

Interventions

DRUG: Naïve patients - ACO therapy
DRUG: Naïve patients - LNDL therapy
DRUG: Naïve patients - MNDL therapy
DRUG: Treatment-experienced patients- LNDL therapy
DRUG: Treatment-experienced patients- MNDL therapy

Sponsor

National Liver Institute, Egypt

Collaborators

[object Object]